Vitamin D and Postpartum Depression
Postpartum depression (PPD) affects ~10-15% of new mothers. Vitamin D deficiency is common in postpartum women — pregnancy demands, breastfeeding transfer, reduced outdoor time with a newborn all combine. Cohort studies link low 25(OH)D with higher PPD risk; small trials suggest supplementation may help.
Observational data
Meta-analyses (Aghajafari 2018 and others) find women with PPD have lower mean 25(OH)D than non-depressed postpartum women. Effect sizes vary but the association is reasonably consistent across cohorts.
Supplementation trials
Vaziri 2016 randomised women with PPD and 25(OH)D deficiency to vitamin D or placebo for 8 weeks — EPDS (Edinburgh Postnatal Depression Scale) improved more with vitamin D. Sample sizes small; larger trials pending.
Evidence-based PPD management
- Universal PPD screening at postpartum visits (EPDS, PHQ-9).
- Psychotherapy (CBT, interpersonal therapy) first-line for mild-moderate PPD.
- SSRIs (sertraline is first-line if breastfeeding — extensive lactation safety data) for moderate-severe PPD.
- Brexanolone (IV allopregnanolone) and zuranolone (oral) — newer options for severe PPD.
- Vitamin D correction if deficient; not a substitute for the above.
- Sleep support, social support, partner involvement.
Postpartum vitamin D adequacy
All postpartum women should continue vitamin D supplementation — the RDA during lactation is 600 IU/day and clinical practice often uses 1,000-2,000 IU/day. Breastfeeding mothers taking 6,400 IU/day can meet the exclusively-breastfed infant's requirement without direct infant drops (see our infants page).